Avexxin Company Profile

Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of the biology of the inflammatory process has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders. Our discovery and clinical development expertise is focused on providing disease-modifying drugs addressing inflammatory disorders that are not adequately treated with existing therapies

Location

Norwegian University of Science and TechnologyHøgskoleringen 5TrondheimN-7491Norway

Contact

Phone: 47 73 59 61 07Fax: 47 73 59 61 00Email: avexxin@avexxin.com

News Articles
[0 Results]

None

Drugs and Medications
[0 Results]

None

PubMed Articles
[0 Results]

None

Clinical Trials
[0 Results]

Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of t...